In the serum of cancer patients, gal-3 concentration levels can range from 20–620 ng/mL (0.74–22 nM) in breast cancer; 20–950 ng/mL (0.74–35 nM) in gastrointestinal tumors; 20–807 ng/mL (0.74–29 nM) in lung cancer; and 35–366 ng/mL (1.3–12.4 nM) in ovarian cancer [39]. Here, LGALS3 is linked to lung carcinoma.